题名 | Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial | 链接 | https://pubmed.ncbi.nlm.nih.gov/37778358/ |
https://pubmed.ncbi.nlm.nih.gov/37778358/ |